Evidence map›Paper›PMID 31225722›Full record

ArticleJournal of cachexia, sarcopenia and muscle2019

Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function.

Christian M Girgis, Kuan Minn Cha, Benjamin So, Michael Tsang, Jennifer Chen, Peter J Houweling, Aaron Schindeler, Rebecca Stokes, Michael M Swarbrick, Frances J Evesson and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Vitamin DJournal of cachexia, sarcopenia and muscle · 2021
    Trial
  6. Trial
  7. Trial
  8. The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Osteosarcopenia in Chronic Kidney Disease: An Overlooked Syndrome?Journal of cachexia, sarcopenia and muscle · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Christian M GirgisDepartment of Diabetes and Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia.
Kuan Minn ChaThe Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Benjamin SoThe Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Michael TsangThe Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Jennifer ChenThe Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Peter J HouwelingMurdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
Aaron SchindelerFaculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.
Rebecca StokesThe Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Michael M SwarbrickFaculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.
Frances J EvessonFaculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.
Sandra T CooperFaculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.
Jenny E GuntonDepartment of Diabetes and Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-8127-9773
The University of Sydney · AURoyal Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has long been recognized that vitamin D deficiency is associated with muscle weakness and falls. Vitamin D receptor (VDR) is present at very low levels in normal muscle. Whether vitamin D plays a direct role in muscle function is unknown and is a subject of hot debate. Myocyte-specific deletion of VDR would provide a strategy to answer this question.

methodsMyocyte-specific vitamin D receptor (mVDR) null mice were generated by crossing human skeletal actin-Cre mice with floxed VDR mice. The effects of gene deletion on the muscle phenotype were studied in terms of body tissue composition, muscle tissue histology, and gene expression by real-time PCR.

resultsUnlike whole-body VDR knockout mice, mVDR mice showed a normal body size. The mVDR showed a distinct muscle phenotype featuring reduced proportional lean mass (70% vs. 78% of lean mass), reduced voluntary wheel-running distance (22% decrease, P = 0.009), reduced average running speed, and reduced grip strength (7-16% reduction depending on age at testing). With their decreased voluntary exercise, and decreased lean mass, mVDR have increased proportional fat mass at 20% compared with 13%. Surprisingly, their muscle fibres showed slightly increased diameter, as well as the presence of angular fibres and central nuclei suggesting ongoing remodelling. There were, however, no clear changes in fibre type and there was no increase in muscle fibrosis. VDR is a transcriptional regulator, and changes in the expression of candidate genes was examined in RNA extracted from skeletal muscle. Alterations were seen in myogenic gene expression, and there was decreased expression of cell cycle genes cyclin D1, D2, and D3 and cyclin-dependent kinases Cdk-2 and Cdk-4. Expression of calcium handling genes sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) Serca2b and Serca3 was decreased and Calbindin mRNA was lower in mVDR muscle.

conclusionsThis study demonstrates that vitamin D signalling is needed for myocyte function. Despite the low level of VDR protein normally found muscle, deleting myocyte VDR had important effects on muscle size and strength. Maintenance of normal vitamin D signalling is a useful strategy to prevent loss of muscle function and size.

Indexed as

ActinsAnimalsCell Cycle ProteinsDown-RegulationGene Knockout TechniquesHumansMaleMiceMuscle, SkeletalOrgan SizeOrgan SpecificityReceptors, CalcitriolSarcopeniaVitamin D DeficiencyActinsCell Cycle ProteinsReceptors, CalcitriolVdr protein, mouseMuscleSarcopeniaVitamin DVitamin D receptorWeakness

Identifiers

PMID31225722
PMCPMC6903451
OpenAlexW2953088247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.